Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 15. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8912  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178239  
   
[¹â¸F]PSMA-1007 PET/CT in biochemical recurrence after radical prostatectomy: A single-center experience of detection rate and lesion distribution.
PLoS One
Wang Y, Feng L, He L, Liu N, Wang H.
PMID: 42133652 [PubMed - indexed for MEDLINE]


UBE2S emerges as a key driver in an NK cell-based prognostic model for clear cell renal cell carcinoma.
PLoS One
Leng K, Zhou Y, Zhao J, Wang X, Song H.
PMID: 42133651 [PubMed - indexed for MEDLINE]


Single-port EDGE SP1000 versus multi-port Da Vinci Xi robot-assisted radical prostatectomy: a comparative analysis of technique and perioperative outcomes.
J Robot Surg
Zhang J, Zhou L, Li H, Du H, Wang H, Tai S, Liang C.
PMID: 42133277 [PubMed - indexed for MEDLINE]


A Bioinspired Three-Dimensional High-Curvature Nano-Interface Integrated Microfluidic Chip for Small Extracellular Vesicles Enrichment and Machine Learning-Assisted Prostate Cancer Precision Diagnosis.
Adv Sci (Weinh)
Wang L, Liang Y, Sulaiman M, Du J, Jiang M, Wang Z, Yu X, Xu L.
PMID: 42133268 [PubMed - as supplied by publisher]


The role of extracellular vesicles-associated proteins markers in prostate cancer: a review.
Discov Oncol
Said DS, Abdullah MNH, Nurdin A.
PMID: 42133214 [PubMed - as supplied by publisher]


APOE ε2/ε3 is associated with multi-layered protection against prostate cancer in Chinese men.
World J Urol
Wang K, Zhang S, Chen M, Duan X, Xie Y, Yang X, Zhong Y, Yu P, Yang M, Wei Z, Tao Z, Liu W.
PMID: 42133096 [PubMed - indexed for MEDLINE]


Chemotherapy-induced anemia as a prognostic factor for overall survival in patients with bladder cancer treated with neoadjuvant cisplatin-based chemotherapy and cystectomy.
World J Urol
Lafitte E, Sfumato P, Walz J, Billon E, Branger N, Vicier C, Rybikowski S, Guérin M, Maubon T, Beaufils M, Seguin L, Salem N, Brunelle S, Pignot G, Gravis G.
PMID: 42132947 [PubMed - indexed for MEDLINE]


Toward multimodal integration of colorectal cancer and chronic kidney disease: transcriptomic modeling as a framework for the SIRIO study "Spatial radiomics and transcriptomics to the discovery of the cross-link between colon cancer and chronic kidney disease".
Radiol Oncol
Fusco R, Granata V, Belli A, F Perna A, Capasso G, Caraglia M, Pace U, Delrio P, Docimo L, Gambardella C, Lucido FS, Floris M, Locci G, Runfola M, Giannascoli D, Izzo M, Sorgente E, Borriello M, Izzo F, Simeoni M, Petrillo A, SIRIO Trial Collaborators.
PMID: 42132448 [PubMed - as supplied by publisher]


Interobserver variability in dominant intraprostatic lesion delineation using (68)Ga-PSMA PET/CT for localized prostate cancer.
Rep Pract Oncol Radiother
Devran BZ, Cetin IA, Cagliyan F, Özgüven S, Öne.
PMID: 42131465 [PubMed]


Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma.
Int J Surg Case Rep
Shrivastava N, Mitra S, Pande S.
PMID: 42130550 [PubMed]


Plasmon-Enhanced Magnetic Fluorescent Nanoprobe for Ultrasensitive Detection of Urinary miRNA-96 Enabling Early Diagnosis and Risk Stratification of Bladder Cancer.
Anal Chem
Zhang D, Li M, Yang B, Yan Z, Ding C, Huang Y.
PMID: 42130209 [PubMed - as supplied by publisher]


Exploring the Efficacy of Immunotherapy in Combination with Surgical Resection in High-risk Muscle-invasive Bladder Cancer.
Iran J Allergy Asthma Immunol
Li Z, Liu C, Wang H.
PMID: 42130139 [PubMed - indexed for MEDLINE]


Rezvilutamide in combination with androgen deprivation therapy (ADT) with or without docetaxel in the neoadjuvant treatment of oligometastatic prostate cancer (REDOOM): study protocol for an open-label, parallel-cohort, multicentre clinical study.
BMJ Open
Chen ZJ, Zhu XX, Huang H, Ding YZ, Zhuang YD, Wang L, Li P, Yu KY, Chen HD, Wang HL, Li HY, Cai B, Deng ZX, Pan Y, Yang Y, Li P, Huang KT, Ji XW, Lin Q, Chen W.
PMID: 42129992 [PubMed - indexed for MEDLINE]


Bladder cancer segmentation using u-net-based deep-learning.
Sci Rep
Patil B, Hadjiiski L, Sun D, Chan HP, Cohan RH, Caoili EM, Zhou C.
PMID: 42129500 [PubMed - as supplied by publisher]


The impact of tissue detection on diagnostic artificial intelligence algorithms in prostate digital pathology.
Sci Rep
Boman SE, Mulliqi N, Blilie A, Ji X, Szolnoky K, Gudlaugsson E, Janssen EAM, Kjosavik SR, Asenjo J, Gambacorta M, Libretti P, Braun M, Kordek R, , Hotakainen K, Väre P, Pedersen BG, Sørensen KD, Ulhøi BP, Egevad L, Kartasalo K.
PMID: 42129415 [PubMed - indexed for MEDLINE]


Decoding the Raf-Mek-Erk-Rsk pathway in prostate cancer: from molecular mechanisms to clinical opportunities.
Br J Cancer
Waldron NR, Silva D, Westaby D, Jiménez-Vacas J, Taylor J, Sharp A.
PMID: 42129337 [PubMed - as supplied by publisher]


Diabetes mellitus and health-related quality of life in long-term survivors of breast, colorectal or prostate cancer: a population-based prospective study.
Br J Cancer
Yang K, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, Eberle A, Holleczek B, Nennecke A, Waldmann A, Zeissig SR, Pritzkuleit R, Jansen L, Brenner H, Arndt V.
PMID: 42129336 [PubMed - as supplied by publisher]


Imaging-based clinical decision tree enables risk stratification of extraprostatic extension before radical prostatectomy in prostate cancer patients.
Insights Imaging
Hamm CA, Rüterhenke T, Baumgärtner GL, Mayerosch C, Schallenberg S, Lindholz M, Beetz NL, Asbach P, Penzkofer T.
PMID: 42129021 [PubMed]


Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancer.
World J Urol
Cournède M, Gabriel PE, Lottin M, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Alvarez-Maestro M, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E.
PMID: 42128947 [PubMed - indexed for MEDLINE]


Outcomes of Intermediate Risk Non-muscle-invasive Bladder Cancer Receiving Adjuvant Treatment: A Pooled Analysis of Four Randomized Controlled Trials.
Eur Urol Oncol
Tan WS, Kamat AM, Lewis R, Porta N, Ackerman C, Vadiveloo T, Penegar S, Martini A, Vale L, Mostafid H, MacLennan G, Hall E, Heer R, Kelly JD.
PMID: 42128773 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 178239    Seite 1 von 8912  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1